Trial Information

Summary: Diabetes Study CLAF237A 23138

The purpose of this study is to determine if an investigational drug is safe to lower blood sugar in patients with diabetic nephropathy. Diabetic Nephropathy is a term used to describe kidney disease that occurs as a result of diabetes. An "investigational drug" is a drug that is being tested and is not approved for sale in the United States by the U.S. Food and Drug Administration (FDA).

The study will up to take up to 26 weeks (6 months 2 weeks). The participant will be required to visit the study center at least 9 times. After completing the study, participants may be asked to join a study extension.
For more information about this clinical trial, visit www.NovartisClinicalTrials.com

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: September 5, 2008 at 3:14:42 PM